Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Higa S
Possible Benefits of Direct Oral Anticoagulants for the Electrophysiological Substrate Properties of Atrial Fibrillation: Can These New Agents Have Antiatrial Fibrillation Actions?
Cardiovascular Pharmacology: Open Access
Related publications
New Anticoagulants for Atrial Fibrillation
Seminars in Thrombosis and Hemostasis
Cardiovascular Medicine
Hematology
Cardiology
The Use of Novel Oral Anticoagulants in Atrial Fibrillation
Cardiovascular and Hematological Disorders - Drug Targets
Molecular Medicine
Pharmacology
Cardiology
Hematology
Cardiovascular Medicine
Medicine
Cost-Effectiveness of Oral Anticoagulants for Treatment of Atrial Fibrillation
Circulation. Cardiovascular quality and outcomes
Medicine
Cardiovascular Medicine
Cardiology
Overview of the Non-Vitamin K Oral Anticoagulants for Atrial Fibrillation
Therapeutic Advances in Cardiovascular Disease
Cardiovascular Medicine
Pharmacology
Cardiology
Periprocedural Management of New Oral Anticoagulants in Patients Undergoing Atrial Fibrillation Ablation
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Risks and Benefits of Direct Oral Anticoagulants Across the Spectrum of GFR Among Incident and Prevalent Patients With Atrial Fibrillation
Clinical Journal of the American Society of Nephrology
Epidemiology
Nephrology
Critical Care
Transplantation
Intensive Care Medicine
Safety and Efficacy of Direct Oral Anticoagulants for Atrial Fibrillation in Patients With Renal Impairment
Pharmacy
Cost-Effectiveness of New Oral Anticoagulants for Patients With Atrial Fibrillation – A Decision Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Satisfaction With Oral Anticoagulants in Patients With Atrial Fibrillation
Patient Preference and Adherence
Pharmacology
Health Policy
Medicine
Toxicology
Social Sciences
Pharmaceutics
